Printer Friendly
The Free Library
14,508,224 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

BDSI to Continue Listing on Nasdaq Small Cap Market.


NEWARK, N.J. -- BioDelivery Sciences International, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:BDSI BDSI Brooks Divinity School, Inc (Denver, CO) )(NASDAQ:BDSIW) today announced that on November 29, 2004, the company received the final determination letter from the Nasdaq Hearing Panel regarding BDSI's continued listing on the Nasdaq SmallCap Market. The company was notified that such panel has determined to continue BDSI's listing, that the hearing file has been closed and that no continued monitoring has been mandated at present. As a result of this determination, effective today, Wednesday, December 1, 2004, BDSI has returned to normal trading status under the "BDSI" ticker symbol Ticker Symbol

An arrangement of characters (usually letters) representing a particular security listed on an exchange or otherwise traded publicly. When a company issues securities to the public marketplace, it selects an available ticker symbol for its securities which investors
.

BioDelivery Sciences International, Inc. is a biotechnology company that is developing and seeking to commercialize patented and licensed delivery technologies for pharmaceuticals, vaccines, over-the-counter drugs, nutraceuticals and micronutrients This is a list of micronutrients.

Vitamins
  • Vitamin A (retinol)
  • Vitamin B complex
  • Vitamin B1 (thiamin)
  • Vitamin B2 (riboflavin)
. The company's technologies include: (i) the patented Bioral(TM) nanocochleate technology, designed for a potentially broad base of applications, and (ii) the patented BEMA(TM) (buccal buc·cal
adj.
1. Of, relating to, adjacent to, or in the direction of the cheek.

2. Of or relating to the mouth cavity.


buccal
 or mouth) drug delivery technology being developed by the company's Arius Pharmaceuticals subsidiary with a focus on "acute" treatment opportunities for surgical and oncology patients.

Note: Except for the historical information contained herein, this press release contains, among other things, certain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995, that involve risks and uncertainties. Such statements may include, without limitation, statements with respect to the Company's plans, objectives, expectations and intentions and other statements identified by words such as "may", "could", "would", "should", "believes", "expects", "anticipates", "estimates", "intends", "plans" or similar expressions. These statements are based upon the current beliefs and expectations of the Company's management and are subject to significant risks and uncertainties, including those detailed in the Company's filings with the Securities and Exchange Commission. Actual results may differ from those set forth in the forward-looking statements. These forward-looking statements involve certain risks and uncertainties that are subject to change based on various factors (many of which are beyond the Company's control).

L.G. Zangani, LLC (Logical Link Control) See "LANs" under data link protocol.

LLC - Logical Link Control
 provides financial public relations Financial public relations

Public relations division of a company charged with cultivating positive investor relations and proper disclosure information.
 service to the Company. As such L.G. Zangani, LLC and/or its officers, agents and employees, receives remuneration for public relations and or other services in the form of monies, capital stock in the Company, warrants or options to purchase capital in the Company.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Dec 1, 2004
Words:370
Previous Article:ManageSource Research, Inc. Initiates Research Coverage of Omni Medical Holdings, Inc.
Next Article:Vault Releases New Employee Surveys on Sun Microsystems.



Related Articles
PSC seeks to retain small-cap standing.(Business)
BDSI Announces Final Equity Line of Credit Agreement; Also, Nasdaq Hearing Agenda Set for Thursday, September 9, 2004.
BDSI Elevates Sirgo and Finn to New Positions.
BDSI Granted NASDAQ Exception for Continued Listing on the SmallCap Market.
Sirgo Appointed President of BDSI.
BDSI Completes Clinical Trials for its Formulation of Emezine.
BDSI Announces Director Resignations; Donald Ferguson and Alan Pearce Resign So That Company Can Comply with Nasdaq Independence Rules.
BioDelivery Sciences International to Present at Wall Street Analyst Forum.
BioDelivery Sciences Retains The Investor Relations Group of New York.
Survey cites payouts, audit fees in higher costs for public firms.(NEWS ROUNDUP)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles